BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1210301)

  • 1. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 4. [ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
    Labò G; Barbara L; Gasbarrini G; Roda E; Schiavina M; Bonvicini F
    Minerva Med; 1972 Oct; 63(75):4055-9. PubMed ID: 4563998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of immunosuppressive therapy in chronic hepatitis].
    Buligescu L
    Med Interna (Bucur); 1972 Mar; 24(3):277-84. PubMed ID: 4112750
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
    Kurdybaĭlo FV; Larina IG; Kulikova AN
    Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic results of the use of Leukeran as an immunosuppressive agent in chronic hepatitis].
    Phlippen R; Schumacher K; Gross R; Eder M
    Tijdschr Gastroenterol; 1970; 13(2):114-28. PubMed ID: 4921502
    [No Abstract]   [Full Text] [Related]  

  • 11. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
    Rudyk BI
    Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis and liver cirrhosis with 6-mercaptopurine and a methylhydrazine derivative].
    Göggel KH; Epperlein H
    Med Klin; 1965 Aug; 60(34):1362-8. PubMed ID: 5843139
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aggressive chronic hepatitis and non-alcoholic cirrhosis of moderate activity and immunosuppressive treatment].
    de Groote J; Fevery J; Vandenbroucke J
    Arch Fr Mal App Dig; 1971 Dec; 60(12):664-9. PubMed ID: 5158156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.